Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site’s footer revision identifier was updated from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T02:36:21.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The completed Phase 2 study of imsidolimab for generalized pustular psoriasis is now displayed with its trial details, participant criteria, locations, measured outcomes, and supporting documents, replacing the 403 error page.
    Difference
    48%
    Check dated 2026-11-11T01:45:59.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-03T23:56:30.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology during the transition from “Artificial Intelligence” to “Super Intelligence” was added, and the site revision changed from v3.7.1 to v3.7.2. The study page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:00:01.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:17:01.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study details and documents with an access-restricted view.
    Difference
    17%
    Check dated 2026-09-23T00:12:03.000Z thumbnail image

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.